Pacific Phoenix TMS
Pacific Phoenix TMS is a private Pacific Northwest psychiatry practice operating three Washington state clinics that delivers NeuroStar TMS, accelerated SAINT-based TMS, Spravato, ketamine therapy, and medication management for treatment-resistant depression, OCD, PTSD, anxiety, and veteran mental health.
- Company typePrivate
- Founded-
- HeadquartersVancouver, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Pacific Phoenix TMS does
Pacific Phoenix TMS (legal name: Pacific Phoenix Psychiatry & TMS) is a private outpatient psychiatry practice headquartered in Vancouver, Washington, operating three clinic locations across East Vancouver, Salmon Creek, and Steilacoom-Lakewood WA, with marketing reach extending to Portland, OR. The practice provides a coordinated suite of advanced mental health treatments built around transcranial magnetic stimulation (TMS) using NeuroStar Advanced Therapy hardware, with protocol variants that include traditional 6-week TMS (36 sessions of 3-18 minutes each), accelerated SAINT-based TMS completed in 1-2 weeks, and AMPA TMS delivered in 3-minute sessions. Adjacent service lines include Spravato (esketamine nasal spray), IM ketamine therapy, psychiatric medication management, and GeneSight pharmacogenomic testing. Conditions treated include major depressive disorder, treatment-resistant depression, OCD, PTSD, anxiety, and military/veteran mental health conditions, with FDA-cleared use spanning adolescents (ages 15+) through adults.
The practice is led by Medical Director Dr. Elia Gonzalez-Rodriguez, MD, supported by three additional board-certified psychiatrists and a psychiatric mental health nurse practitioner, with the clinical team having delivered approximately 10,000 TMS sessions cumulatively. Revenue is generated through per-session insurance reimbursement across 14+ major payers (Blue Cross Blue Shield, Tricare, Aetna, Cigna, United Healthcare, Kaiser, Providence, Premera, Regence, Pacific Source, MHN, ComPsych, Anthem, First Choice, and Optum) plus self-pay options for accelerated SAINT protocols not covered by insurance, with financing offered through AdvanceCare and CareCredit. Customer acquisition combines direct patient outreach (phone, online appointment requests), physician referral networks, content marketing across a 40+ article blog and four social media channels (Facebook, Instagram, YouTube, TikTok), and a Blue Star Families Puget Sound chapter sponsorship targeting the Tricare-holding veteran segment. The practice holds Diamond Rated NeuroStar provider status (highest tier) and Better Me Guarantee designation.
Pacific Phoenix TMS firmographics
Firmographics- Name
- Pacific Phoenix TMS
- Legal name
- Pacific Phoenix Psychiatry & TMS
- Website
- https://pacpx.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Pacific Phoenix TMS is a private Pacific Northwest psychiatry practice operating three Washington state clinics that delivers NeuroStar TMS, accelerated SAINT-based TMS, Spravato, ketamine therapy, and medication management for treatment-resistant depression, OCD, PTSD, anxiety, and veteran mental health.
- Ownership category
- akta.pro rank
Pacific Phoenix TMS industry classification
Industry- Product category
- Mental Health Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)
- akta.pro secondary industry
- Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)
Keywords
Where Pacific Phoenix TMS is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Pacific Phoenix TMS business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Psychiatry and TMS Treatment Services: Revenue generated from providing psychiatric services including medication management, TMS therapy sessions, ketamine treatments, Spravato administration, and other mental health treatments. Services are billed per session or treatment protocol. Insurance reimbursement is a primary revenue source with most major insurance plans accepted including Blue Cross, Tricare, Aetna, Cigna, United Healthcare, and others.
- Self-Pay/Out-of-Pocket TMS: For patients without insurance coverage or seeking accelerated protocols not covered by insurance (such as SAINT-based TMS), revenue is collected directly from patients. Payment plans available through AdvanceCare and CareCredit financing options.
- GeneSight Genetic Testing: Revenue from pharmacogenomic testing services that help personalize medication selection for mental health treatment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Standard TMS Treatment Protocol - 36 sessions over 6 weeks |
| Unit Pricing | Pay-as-you-go | Accelerated SAINT-based TMS Protocol |
| Subscription | Monthly | Insurance-Based TMS (for covered patients) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
Pacific Phoenix TMS product offering
Product offeringCore offering
Pacific Phoenix TMS is a private psychiatry practice that delivers in-person mental health treatment services centered on Transcranial Magnetic Stimulation (TMS) using NeuroStar Advanced Therapy, alongside Spravato (esketamine), IM ketamine therapy, pharmacogenomic GeneSight testing, and personalized psychiatric medication management. The practice treats treatment-resistant depression, OCD, PTSD, and anxiety in patients aged 15 and older across three Washington-state clinic locations, with specialized services for military veterans.
Product overview
Pacific Phoenix TMS is a psychiatric practice offering a coordinated suite of mental health treatment services centered on advanced neuromodulation therapies. The core offering is Transcranial Magnetic Stimulation (TMS) using NeuroStar Advanced Therapy technology, with multiple protocol variants including traditional TMS, accelerated SAINT-based TMS, and AMPA TMS (3-minute treatments). Supporting treatments include Spravato (esketamine nasal spray) and IM Ketamine Therapy for treatment-resistant depression. The practice also provides medication management, GeneSight genetic testing for personalized medication selection, and specialized programs for military veterans. Treatment is organized by condition (depression, anxiety, PTSD, OCD) with services delivered across three clinic locations in the Vancouver/Lakewood, WA area.
Differentiator
Problem solved
Functional benefit
Products and services
- Transcranial Magnetic Stimulation (TMS) FDA-approved non-invasive treatment using magnetic fields to stimulate brain regions associated with mood regulation. Delivered via NeuroStar Advanced Therapy technology to treat major depressive disorder, OCD, and other mood disorders in patients aged 15+. Standard protocol involves 5 sessions per week for approximately 6 weeks with each session lasting 3-18 minutes.
- Accelerated SAINT-based TMS Protocol Accelerated TMS protocol based on Stanford University's SAINT protocol that delivers treatment results in 1-2 weeks instead of the traditional 6-12 weeks. Involves multiple short sessions per day over 5-7 consecutive days. Self-pay only (not covered by insurance).
- AMPA TMS Three-minute accelerated TMS treatment option for major depressive disorder, offering faster treatment delivery than traditional TMS sessions.
- Spravato (Esketamine) FDA-approved nasal spray medication containing esketamine for treatment-resistant depression. Administered in-office under clinical supervision. Works rapidly on glutamate neurotransmitters and can provide symptom relief including reduction of suicidal thoughts within hours. Used in conjunction with oral antidepressants.
- IM Ketamine Therapy Intramuscular ketamine administration for treatment-resistant depression, providing faster-acting relief compared to traditional antidepressants. Patients monitored in-office for at least two hours post-treatment.
- Medication Management Personalized psychiatric medication management services including ongoing monitoring and adjustment of psychotropic medications for patients with mental health conditions.
- GeneSight Testing Pharmacogenomic genetic testing that analyzes how a patient's genes affect their response to psychiatric medications, helping clinicians personalize medication selection for mental health treatment.
- Military and Veteran Services Specialized mental health program for active duty military personnel and veterans, covering PTSD, depression, traumatic brain injury, military sexual trauma, and other service-related conditions. Includes a guarantee to be seen within two weeks of initial inquiry for veterans. Accepts Tricare insurance.
- Depression Treatment Comprehensive treatment services for major depressive disorder and treatment-resistant depression using multiple modalities including TMS, ketamine, Spravato, and medication management.
- Anxiety Treatment Mental health treatment services for anxiety disorders including generalized anxiety disorder, panic disorder, and phobias.
- PTSD Treatment Treatment services for post-traumatic stress disorder using therapies including TMS, medication management, and counseling referrals.
- OCD Treatment Treatment services for obsessive-compulsive disorder, including TMS therapy which is FDA-approved for OCD and may be covered by some insurance plans (e.g., Cigna).
Quantifiable outcome
- 30-60%+ response rate for treatment-resistant depression
- +5 more outcomes
Companies that use Pacific Phoenix TMS
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Pacific Phoenix TMS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Pacific Phoenix TMS partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Blue Star Families (Puget Sound Chapter)minorPacific Phoenix Psychiatry & TMS sponsors the Puget Sound chapter of Blue Star Families, a national nonprofit connecting military families with community resources. The partnership supports the mental health of military personnel, veterans, and their families through visibility and sponsorship.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
Pacific Phoenix TMS competitors and assessment
Company assessmentBroad incumbents
- Greenbrook TMS: Largest U.S. network of TMS treatment centers operating hundreds of locations; same NeuroStar-based service model but at vastly greater scale, serving as the broad incumbent reference set.
- Lifestance Health: Large, publicly-traded outpatient mental health platform with extensive insurance contracts and a growing interventional psychiatry offering; sets the broader competitive and reimbursement benchmark.
Direct peers
- Cedar Psychiatry: Interventional psychiatry practice offering TMS, ketamine, and Spravato; closely comparable mid-sized specialty clinic competing for similar treatment-resistant and self-pay patients.
- Actify Neurotherapies: Multi-state interventional psychiatry group delivering TMS, ketamine, and SPRAVATO across clinics; comparable in modality mix and regional multi-site footprint.
- Mindful Health Solutions: Multi-location outpatient psychiatry practice specializing in TMS, ketamine, and Spravato for treatment-resistant depression and anxiety, closely matching Pacific Phoenix's multi-modality neuromodulation model.
- TMS Health Solutions: Bay Area TMS-focused psychiatry group offering NeuroStar TMS and other interventional treatments; the most direct specialty-practice peer with a similar clinician-driven, neuromodulation-centric delivery model.
- Ketamine Clinics of Los Angeles: Specialty clinic network offering ketamine and Spravato for treatment-resistant mood disorders; comparable as a destination interventional-psychiatry practice with similar self-pay economics.
Emerging players
- Brightside Health: Telehealth-first mental health provider expanding into medication management and interventional care; an emerging threat/adjacent competitor for treatment-resistant patients willing to use remote channels.
- Talkiatry: Tech-enabled outpatient psychiatry group accepting insurance across multiple states; an emerging player competing for similar patient referrals and insurance panels, especially via PCP channels.
Others
- Neuronetics (NeuroStar): Manufacturer of the NeuroStar TMS platform used by Pacific Phoenix; an enabling ecosystem participant whose commercial and clinical decisions directly shape the practice's product roadmap and economics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Pacific Phoenix TMS social profiles
Digital presencePacific Phoenix TMS financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pacific Phoenix TMS leadership team
Management profileNumber of profiles
Profiles5 records
Pacific Phoenix TMS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pacific Phoenix TMS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pacific Phoenix TMS
What does Pacific Phoenix TMS do?
Pacific Phoenix TMS is a private psychiatry practice that delivers in-person mental health treatment services centered on Transcranial Magnetic Stimulation (TMS) using NeuroStar Advanced Therapy, alongside Spravato (esketamine), IM ketamine therapy, pharmacogenomic GeneSight testing, and personalized psychiatric medication management. The practice treats treatment-resistant depression, OCD, PTSD, and anxiety in patients aged 15 and older across three Washington-state clinic locations, with specialized services for military veterans.
Is Pacific Phoenix TMS a public or private company?
Pacific Phoenix TMS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pacific Phoenix TMS founded?
Pacific Phoenix TMS was founded in -1. It employs 1 to 10 people.
Where is Pacific Phoenix TMS based?
Pacific Phoenix TMS is headquartered in Vancouver, United States, in the North America region.
How does Pacific Phoenix TMS make money?
Three revenue lines are on record. Psychiatry and TMS Treatment Services are the primary driver. The others are self-Pay/Out-of-Pocket TMS and geneSight Genetic Testing.
Who are Pacific Phoenix TMS's main competitors?
Broad incumbents on record are Greenbrook TMS and Lifestance Health. Direct peers are Cedar Psychiatry, Actify Neurotherapies, Mindful Health Solutions, TMS Health Solutions and Ketamine Clinics of Los Angeles. Emerging players are Brightside Health and Talkiatry. Neuronetics (NeuroStar) is listed as an others.
Does Pacific Phoenix TMS have an API?
No public API is recorded for Pacific Phoenix TMS.
What industry is Pacific Phoenix TMS in?
Pacific Phoenix TMS's product category is Mental Health Services. Its primary akta.pro industry code is HSADAIAC, Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS), with a secondary code of HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching). Its NAICS code is 621112 and its SIC code is 8011.